SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced Enchant™, a ...
Revolution Medicines, a late-stage clinical oncology company, and Iambic Therapeutics, an AI-driven drug discovery company, have announced a multi-year technology and research collaboration to pursue ...
Three researchers wearing blue lab coats in a laboratory Iambic uses both physics- and AI-based machine learning models. Credit: Iambic Therapeutics Iambic Therapeutics, a San Diego–based start-up ...
Takeda Pharmaceutical will apply Iambic Therapeutics’ artificial intelligence (AI)-based technologies and wet lab capabilities to design and develop small molecule drugs starting with two of Takeda’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results